NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
MITODAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
05/20/2025
Trademark type
Word
Nice classes
5
Filing date
10/11/2022
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Chungcheongbuk-do,, KR
Examiner
CHANG, KATHERINE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Curome Biosciences Co., Ltd.
Representatives
James J. Saul FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical drugs for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical compositions for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceuticals for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; nutraceutical preparations for therapeutic or medical purposes for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the treatment of degenerative brain disease
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/21/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/03/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/03/2024
CNSI
SUSPENSION INQUIRY WRITTEN
12/03/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/03/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/03/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/31/2024
GNSL
LETTER OF SUSPENSION E-MAILED
01/31/2024
CNSL
SUSPENSION LETTER WRITTEN
01/31/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/26/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/26/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/26/2023
GNRT
NON-FINAL ACTION E-MAILED
07/26/2023
CNRT
NON-FINAL ACTION WRITTEN
07/26/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/26/2023
GNSL
LETTER OF SUSPENSION E-MAILED
07/26/2023
CNSL
SUSPENSION LETTER WRITTEN
07/26/2023
DOCK
ASSIGNED TO EXAMINER
07/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2022
NWAP
NEW APPLICATION ENTERED
10/14/2022
Continuous trademark protection
Get notified about every new filing that threatens MITODAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.